Professor Marc-Andre Gagnon investigates how the innovation system in the pharmaceutical sector is broken. In the last 15 years, fewer new drugs have arrived on the market, and the vast majority of them do not represent any therapeutic advancement as compared to what already exist. However, promotional expenditures surged during that period and, according to dominant pharmaceutical companies' annual reports, they are gaining record profits in spite of the lack of therapeutic innovation.... Read more about The Political Economy of Pharmaceutical Corruption: How to Reconcile Profits and Public Health in the Pharaceutical Sector?